Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solution equilibria of deferoxamine amides.

Peter M Ihnat1, Jonathan L Vennerstrom, Dennis H Robinson

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center 986025, Omaha, Nebraska 68198-6025, USA. peter.ihnat@pcorp.com

Journal of Pharmaceutical Sciences
|July 13, 2002
PubMed
Summary

Deferoxamine analogs were synthesized and tested for iron binding. Modifications retained iron-binding ability, with slight stability changes in iron complexes under physiological conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-Activity Relationship of Antischistosomal Aryl Hydantoin (AR102).

Journal of medicinal chemistry·2025
Same author

Spleen and peripheral blood immunopathology in an outbred model of adult-stage murine schistosomiasis.

Frontiers in immunology·2025
Same author

Comparative Hydrophobicity, Solubility, and Metabolic Stability of 4(1<i>H</i>)-Pyridones, 4(1<i>H</i>)-Quinolones, and 9(10<i>H</i>)-Acridones.

ACS medicinal chemistry letters·2025
Same author

Single-Dose Drug Development Candidate for Schistosomiasis.

ACS infectious diseases·2024
Same author

Medium-Ring Keto Bislactams with Antischistosomal Activity.

Journal of medicinal chemistry·2024
Same author

Comparison of capillary electrophoresis-based methods for the analytical characterization of purity and stability of in vitro transcribed mRNA.

Journal of pharmaceutical and biomedical analysis·2024

Area of Science:

  • Medicinal Chemistry
  • Biochemistry
  • Pharmacology

Background:

  • Deferoxamine is a chelator used to treat iron overload.
  • Modifying deferoxamine's structure may alter its iron-binding properties and therapeutic potential.

Purpose of the Study:

  • To synthesize and characterize deferoxamine analogs with modified terminal amino groups.
  • To evaluate the iron(III)-binding constants and complex stabilities of these analogs under physiological conditions.

Main Methods:

  • Acylation of deferoxamine's terminal amino group with various moieties.
  • Potentiometric titration to determine proton dissociation constants.
  • Spectrophotometric analysis to determine iron(III)-binding constants and complex stabilities.

Related Experiment Videos

Main Results:

  • Deferoxamine analogs retained significant iron-binding ability compared to the parent molecule.
  • Proton dissociation and iron binding constants were comparable to deferoxamine.
  • The most lipophilic analog showed slightly decreased iron complex stability, while the succinamide derivative showed slightly increased stability at physiological conditions.

Conclusions:

  • Terminal amino group modifications of deferoxamine generally preserve iron-binding capacity.
  • Subtle changes in lipophilicity and conformation influence the stability of deferoxamine-iron complexes.
  • These findings provide insights for designing improved deferoxamine-based chelators.